← back to search

Scooter Willis

AstraZeneca (Singapore) · SG
Area of research
Cancer Research · Oncology
Research interest
Research interests include Cancer Genomics and Diagnostics, Cancer Immunotherapy and Biomarkers, Breast Cancer Treatment Studies, and HER2/EGFR in Cancer Research.
h-index
17
citations
1,821
works
65
NIH funding
primary concept
email

Recent publications

Scoring of tumor-infiltrating lymphocytes: From visual estimation to machine learning
Seminars in Cancer Biology 2018cited by 166position: middledoi
Effects of Estrogen Receptor and Human Epidermal Growth Factor Receptor-2 Levels on the Efficacy of Trastuzumab
JAMA Oncology 2016cited by 99position: middledoi
BioJava: an open-source framework for bioinformatics in 2012
Bioinformatics 2012cited by 183position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Sylvain Foisy · Université de Montréal1 papers (2012–2012)Spencer Bliven · Paul Scherrer Institute1 papers (2012–2012)Sherene Loi · Peter MacCallum Cancer Centre1 papers (2016–2016)Chuan Hock Koh · Wellcome Trust1 papers (2012–2012)Jianjiong Gao · Dana-Farber Cancer Institute1 papers (2012–2012)Mark A. Chapman · University of Southampton1 papers (2012–2012) · 1 papers (2016–2016) · 1 papers (2016–2016)Varvara Polydoropoulou · Frontier Science Foundation-Hellas1 papers (2016–2016)Bradley Long · Embedded Systems (United States)1 papers (2016–2016)Christos Sotiriou · University of California San Diego1 papers (2016–2016)Mitch Dowsett · Breast Cancer Now1 papers (2016–2016)Andrew Yates · European Bioinformatics Institute1 papers (2012–2012)Stefan Michiels · Institut Gustave Roussy1 papers (2016–2016)Brian Leyland‐Jones · Avera Health1 papers (2016–2016)Peter W. Rose · University of North Carolina at Chapel Hill1 papers (2012–2012)Philip E. Bourne · University of Virginia1 papers (2012–2012)Andreas Prlić · Invitae (United States)1 papers (2012–2012)Evandro de Azambuja · Twitter (United States)1 papers (2016–2016)Julius O.B. Jacobsen · Queen Mary University of London1 papers (2012–2012)